To address the mechanism by which loss of RAS (KRAS in HCT116 and NRAS in IPC298) reduced cellular proliferation and delayed tumor growth, we analyzed cell cycle progression and apoptosis induction in these cells following dox treatment. The gene discussed is KRAS; the disease is neoplasm.